Proteins used in this study A bacterial expression plasmid encoding His 6 -tagged GACKIX domain from mouse CBP (residues 586-672) linked via a polar linker was used to express KIX as previously described.
was buffer exchanged using PD-10 columns into 10 mM phosphate pH 6.8, 100 mM NaCl and concentrated to 90-100 µM using 10 KD molecular weight cutoff concentrators (Vivascience) and stored at -80 °C until use. Protein concentration was determined by UV (ε=14440 M -1 cm -1 ).
Gal4(1-100), Med15 and Med15(107-255) were bacterially expressed and purified as previously described. (3, 4) Peptides used in this study All peptides were synthesized on CLEAR amide resin (Peptides international) using standard HBTU/HOBT/DIEA solid phase peptide synthesis protocols as previously described. (5) The TFA-cleaved peptides were precipitated with ether, purified by reversephased HPLC using a 0.1% TFA/CH 3 CN solvent system and verified by electrospray mass spectrometry.
Fl-MLL19 (FITC-βAla-DCGNILPSDIMDFVLKNTP) used for the screen was synthesized by coupling FITC to βAla-DCGNILPSDIMDFVLKNTP on resin. The concentration of Fl-MLL19 was determined by UV in 10 mM Tris pH 9.0, using ε =77,000 M -1 cm -1 at 494 nM.
Unlabeled MLL15dm (ILPSDI(nLe)DFILKNTY) was used for competition NMR experiments. The sequence contains a C-terminal tyrosine for quantitation. The concentration was determined by UV in in 8M Urea, Tris pH 8.0 using ε = 1420 M -1 cm -1 at 280 nM.
Fl-MLL15dm (FITC-ILPSDI(nLe)DFILKNTY) was used for competitive FP experiments with the depsides and depsidones .
Fl-pKID29 (FITC-AEEA-TDSQKRREILSRRPS(Phos)YRKILNDLSSDAPG) was used for competitive FP experiments with the depsides and depidones. Unlabeled pKID29 (TDSQKRREILSRRPS(Phos)YRKILNDLSSDAPG) was used for competition NMR experiments.
Fl-Myb (FITC-βAla-KEKRIKELELLLMSTENELKGQQALW) was used for competitive FP experiments with the natural product extracts
Fl-VP2 (Fl-DFDLDMLGDFDLDMLG) and unlabeled VP2 (Biotin-DFDLDMLGD(pBpa)DLDMLG) were used to evaluate the specificity of sekikaic acid High Throughput Screen The screen was performed at the Center for Chemical Genomics, University of Michigan. A 50,562 member diverse small molecule library (compounds from Maybridge HitFinder, ChemBridge, ChemDiv, Spectrum, NCI and NIH collection) and a 16,320 natural product extract collection were used to find inhibitors of MLL-GACKIX by fluorescence polarization. The assay was performed in 384-well plates (low volume, NBS, black, 284-well Corning plates #3676). Each plate was set up such that columns 1-22 contained 5 µL of GACKIX at 20 µM in assay buffer (10 mM PBS pH 6.8, 10% glycerol, 0.01% NonidetP-40, 1 mM DTT), and columns 23-24 contained 5 µL assay buffer. DMSO (200 nL, 2% v/v final) was added with a pin-tool to columns 1 and 2, while columns 3-22 received compounds (final concentration 20 µM for small molecules and 0.3 mg/L for extracts), followed by addition of 5 µL, 50 nM Fl-MLL19 in assay buffer with a liquid handler. Samples were incubated for 30 min before being read on a PheraStar Plus (BMG Labtech) plate reader equipped with the Fl-FP module (485nm/520nm).
Initial hits (inhibition >15% or 2.5 SD for small molecule collection, >20% SD for natural product extracts) were analyzed with consultation of Dr. Paul D. Kirchhoff (Vahlteich Medicinal Chemistry Core, University of Michigan) and Martha Larsen (Center for Chemical Genomics, University of Michigan). Confirmation tests on the initial hits were done in an assay with identical final components, but with a different order of addition. For this, the tracers were added first, followed by compounds, and the plates were read once before addition of protein. The first read was used to determine if any of the compounds quenched the fluorescence of the tracer. As described in the text, no small molecule collection-derived hits proceeded past the secondary confirmation tests.
The confirmatory assay yielded 64 hits from the extracts that were also non-fluorescent. These hits were counter-screened using an assay developed by the Grembecka lab (University of Michigan) with the Fl-MBM1-menin protein-protein interaction (Fl-MBM1 was used at 15 nM while menin was used at 150 nM). (6) All of the subsequent hits from the natural product extracts (22 hits) were found to be from lichen extracts isolated in Costa Rica. Fresh extracts were isolated from Costa Rica (Dr. Giselle Tamayo, National Institute for Biodiversity, Costa Rica) and 13 of those were transferred to the University of Michigan. These extracts were separated into 5 individual HPLC fractions to facilitate identification of the active component(s) see below for details. Each fraction was tested for its ability to inhibit Fl-MLL19-GACKIX at three different concentrations 0.8 mg/mL, 0.08 mg/mL and 0.008 mg/mL (Supporting Figure 2 ). Next, the most active of these fractions were tested for specificity using three other FP-assays, c-Fl-Myb-GACKIX, Fl-VP2-Med15(1-345) and Fl-DNA-Gal4(1-100). For these, Fl-cMyb and Fl-VP2 were used at 25 nM and the Fl-DNA tracer was used at 10 nM. GACKIX and Med15 were used at 10 µM and Gal4 protein was used at 50 nM while the extract was used at 0.3 mg/mL.
Fluorescent polarization assay -competitive binding experiments
The FP assays were done in triplicate with a final sample volume of 10 µL in a lowvolume, non-binding, black, 384-well plate (Corning), and read using a Tecan Genios Pro plate reader with polarized excitation at 485 nm and emission intensity measured through a parallel and perpendicularly polarized 535 nm filter. Fl-MLL15dm -GACKIX inhibition curves were done with GACKIX at 1 µM. Fl-KID29 -GACKIX inhibition curves were done with GACKIX at 2.5 µM. In all cases the tracer was kept constant at 25 nM. The obtained data was plotted in Graphpad Prism 5 and fitted with nonlinear regression using built-in equation "log(inhibitor) vs. response -Variable slope (four parameters)" from which the IC 50 was calculated. HPLC fractions found active in FP assays were characterized by NMR spectroscopy, mass spectrometry and UV-vis to determine the identity of their constituents. Extract 2 contained primarily one compound that was active in the assay. This compound was determined to be sekikaic acid (see Supporting Figures 3 and 4 for NMR and mass spectrometry characterization data). Extract 6 contained two active compounds which were determined to be the depsides microphyllinic acid and 5'-O-demethylmicrophyllinic acid (data not shown). For comparative studies lecanoric acid and lobaric acid were purchased from ChromaDex. A UV spectrum of sekikaic acid was recorded, and ε 260 nm = 12196 M -1 cm -1 was measured and used for determination of concentrations. Circular Dichroism CD spectra were acquired on a J-715 spectropolarimeter equipped with a temperature control unit (Jasco, Inc., Easton, MD). Samples of 7.5 µM GACKIX were prepared in the presence and absence of sekikaic acid in 10 mM sodium phosphate pH 6.8, 100 mM NaCl, 0.1% DMSO. CD spectra were recorded at room temperature using a 1 mm pathlength quartz cuvette. Data was acquired by monitoring molar ellipticity from 200-260 nm. Reported data is the average of 5 acquired spectra. The CD signal resulting from the buffer alone was subtracted from the spectrum of each protein solution. Data were converted to mean residue ellipticity (deg cm 2 dmol -1 ) according to the equation:
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where Ψ is the CD signal in degrees, n is the number of amides, l is the path length in centimeters, and c is the concentration in decimoles per cm 3 . Variable temperature CD was acquired by monitoring the molar ellipticity at 222 nm during heating of the protein solutions at a rate of 1 degree/minute from 20-95 °C . Data analysis was performed using GraphPad Prism software.
Computational methods
Molecular dynamics simulations of the natural products in implicit solvent were performed using CHARMM. (7) The simulations revealed that these small molecules prefer to adopt a helical-like conformation in solution. To visually demonstrate that sekikaic acid takes on this type of conformation in solution, the small molecule conformations generated from the simulations were clustered and a representative member from each of the five largest clusters was rigidly fit using Chimera into a pseudo-density map of the p53 peptide generated using the Situs tool with an approximate resolution of 5 angstroms. (8, 9) As shown in Figure 5 b) in the manuscript, which was generated in Chimera, an example of a preferred conformation of sekikaic acid fits well into the pseudo-density map, which supports the idea that it behaves as a helical mimic.
Simulations were run at 300K for 1 nanosecond after an equilibration of 500 picoseconds using the Leapfrog Verlet integrator and a 1 femptosecond timestep. The CHARMM27 all-atom force field was used while the parameters for the small molecules were produced using the atom typing toolset MATCH. (10, 11) GBMV was used as the implicit solvent, with a constant dielectric and a 16 angstrom nonbonded cutoff. Clustering was performed using the MMTSB Tool Set with a 2 angstrom heavy atom RMSD radius. (12) Cellular studies HeLa cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% FBS. 4 x 10 4 cells/well were plated in 24-well format and allowed to adhere overnight. The next day, cells were treated with the natural products delivered in DMSO (1% final v/v). The cells were then grown for 48 h before harvesting. Western blotting was performed using a CYCLIN D1 (sc-718) or GAPDH (sc-44724) antibody. For a positive control, cells were serum-starved for 2 h prior to lysis to deplete CYCLIN D1 levels. Supporting Figure 1 . HSQC of sekikaic acid binding to GACKIX. a) Free 15 N GACKIX is shown in red and GACKIX + 5eq sekikaic acid is shown in blue. Residues that shift significantly are labeled in green. The peak arrows refer to the free GACKIX. b) An experiment similar to a) was performed with a GACKIX construct(1) lacking the stabilizing polar linker between the (His) 6 tag and GACKIX to detect the shift seen with F612 whose resonance is overlapping with a linker residue in a). In this new construct, a significant shift of 0.021 is detected for F612 when 5 eq. of sekikaic acid are added. c) Chemical shift perturbation mapping of GACKIX residues upon addition of 5 eq. of sekikaic acid seen in a). Residues that shift >0.02 are assumed to be significant, see methods for details. Residues that are unable to be detected/assigned in a) are shown in gray. Figure 6 . Conformational rigidity of natural products. Inspection of the natural products simulations in implicit solvent showed that lecanoric acid could rotate around its ester bond more freely than sekikaic acid. To quantify this observation the angle between the two planes defined by the phenyl rings was followed throughout the trajectory (left) and the probability density of those angles sampled were plotted (right). Lecanoric acid has the largest variation in angles sampled, as seen by it's broad probability distribution which spans approximately 160 degrees. Sekikaic acid has a more narrow distribution, peaking at about 95 degrees, indicating it is not as free to rotate around its ester bond. Lobaric acid is limited to sampling angles distributed about 50 degrees as it is restrained by an additional ring.
